|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q101438137
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010629.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q101438137
|
|
035
|
|
|
‡a
(OCoLC)Q101438137
|
|
100
|
0 |
|
‡a
Jens-Uwe Vogel
‡9
en
‡9
nl
|
|
670
|
|
|
‡a
Author's Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model.
|
|
670
|
|
|
‡a
Author's Effects of S-acetylglutathione in cell and animal model of herpes simplex virus type 1 infection
|
|
670
|
|
|
‡a
Author's Expression level of neural cell adhesion molecule (NCAM) inversely correlates with the ability of neuroblastoma cells to adhere to endothelium in vitro
|
|
670
|
|
|
‡a
Author's Impact of persistent cytomegalovirus infection on human neuroblastoma cell gene expression
|
|
670
|
|
|
‡a
Author's In vitro antiviral activity of aphidicolin and its derivates. Synergistic effects of aphidicolin with other antiviral drugs
|
|
670
|
|
|
‡a
Author's Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha
|
|
670
|
|
|
‡a
Author's Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology
|
|
670
|
|
|
‡a
Author's Multimutated herpes simplex virus g207 is a potent inhibitor of angiogenesis.
|
|
670
|
|
|
‡a
Author's Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression
|
|
670
|
|
|
‡a
Author's Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma.
|
|
670
|
|
|
‡a
Author's Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis
|
|
670
|
|
|
‡a
Author's The human eye
|
|
670
|
|
|
‡a
Author's The human eye (retina): a site of persistent HCMV infection?
|
|
670
|
|
|
‡a
Author's The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation
|
|
670
|
|
|
‡a
Author's Thrombin induces Sp1-mediated antiviral effects in cytomegalovirus-infected human retinal pigment epithelial cells
|
|
670
|
|
|
‡a
Author's Thrombin stimulates IL-6 and IL-8 expression in cytomegalovirus-infected human retinal pigment epithelial cells.
|
|
670
|
|
|
‡a
Author's Virology and epidemiology of oral herpesvirus infections
|
|
919
|
|
|
‡a
potentoncolyticactivityofmultimutatedherpessimplexvirusg207incombinationwithvincristineagainsthumanrhabdomyosarcoma
‡A
Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma.
‡9
1
|
|
919
|
|
|
‡a
developmentofresistancetovincristineanddoxorubicininneuroblastomaaltersmalignantpropertiesandinducesadditionalkaryotypechangesapreclinicalmodel
‡A
Development of resistance to vincristine and doxorubicin in neuroblastoma alters malignant properties and induces additional karyotype changes: a preclinical model.
‡9
1
|
|
919
|
|
|
‡a
effectsofsacetylglutathioneincellandanimalmodelofherpessimplexvirustype1infection
‡A
Effects of S-acetylglutathione in cell and animal model of herpes simplex virus type 1 infection
‡9
1
|
|
919
|
|
|
‡a
expressionlevelofneuralcelladhesionmoleculencaminverselycorrelateswiththeabilityofneuroblastomacellstoadheretoendotheliuminvitro
‡A
Expression level of neural cell adhesion molecule (NCAM) inversely correlates with the ability of neuroblastoma cells to adhere to endothelium in vitro
‡9
1
|
|
919
|
|
|
‡a
impactofpersistentcytomegalovirusinfectiononhumanneuroblastomacellgeneexpression
‡A
Impact of persistent cytomegalovirus infection on human neuroblastoma cell gene expression
‡9
1
|
|
919
|
|
|
‡a
invitroantiviralactivityofaphidicolinanditsderivatessynergisticeffectsofaphidicolinwithotherantiviraldrugs
‡A
In vitro antiviral activity of aphidicolin and its derivates. Synergistic effects of aphidicolin with other antiviral drugs
‡9
1
|
|
919
|
|
|
‡a
inductionofdifferentiationandsuppressionofmalignantphenotypeofhumanneuroblastomabe2100cellsbyvalproicacidenhancementbycombinationwithinterferonalpha
‡A
Induction of differentiation and suppression of malignant phenotype of human neuroblastoma BE(2)-C cells by valproic acid: enhancement by combination with interferon-alpha
‡9
1
|
|
919
|
|
|
‡a
molecularmechanismsofthemodulatoryeffectsofhcmvinfectionintumorcellbiology
‡A
Molecular mechanisms of the modulatory effects of HCMV infection in tumor cell biology
‡9
1
|
|
919
|
|
|
‡a
multimutatedherpessimplexvirusg207isapotentinhibitorofangiogenesis
‡A
Multimutated herpes simplex virus g207 is a potent inhibitor of angiogenesis.
‡9
1
|
|
919
|
|
|
‡a
oncomodulatorysignalsbyregulatoryproteinsencodedbyhumancytomegalovirusanovelroleforviralinfectionintumorprogression
‡A
Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression
‡9
1
|
|
919
|
|
|
‡a
roleofhumancytomegalovirusgenotypepolymorphismsinaidspatientswithcytomegalovirusretinitis
‡A
Role of human cytomegalovirus genotype polymorphisms in AIDS patients with cytomegalovirus retinitis
‡9
1
|
|
919
|
|
|
‡a
humaneye
‡A
The human eye
‡9
1
|
|
919
|
|
|
‡a
humaneyeretinaasiteofpersistenthcmvinfection
‡A
The human eye (retina): a site of persistent HCMV infection?
‡9
1
|
|
919
|
|
|
‡a
thrombopoietinreceptoragonisteltrombopaginhibitshumancytomegalovirusreplicationviaironchelation
‡A
The Thrombopoietin Receptor Agonist Eltrombopag Inhibits Human Cytomegalovirus Replication Via Iron Chelation
‡9
1
|
|
919
|
|
|
‡a
thrombininducessp1mediatedantiviraleffectsincytomegalovirusinfectedhumanretinalpigmentepithelialcells
‡A
Thrombin induces Sp1-mediated antiviral effects in cytomegalovirus-infected human retinal pigment epithelial cells
‡9
1
|
|
919
|
|
|
‡a
thrombinstimulatesil6andil8expressionincytomegalovirusinfectedhumanretinalpigmentepithelialcells
‡A
Thrombin stimulates IL-6 and IL-8 expression in cytomegalovirus-infected human retinal pigment epithelial cells.
‡9
1
|
|
919
|
|
|
‡a
virologyandepidemiologyoforalherpesvirusinfections
‡A
Virology and epidemiology of oral herpesvirus infections
‡9
1
|
|
996
|
|
|
‡2
NTA|067807313
|
|
996
|
|
|
‡2
DNB|1146939337
|
|
996
|
|
|
‡2
ISNI|0000000068308715
|
|
996
|
|
|
‡2
BAV|495_39336
|
|
996
|
|
|
‡2
RERO|A003947216
|
|
996
|
|
|
‡2
ISNI|0000000038834140
|
|
996
|
|
|
‡2
DNB|135938805
|
|
996
|
|
|
‡2
NKC|jo2015882531
|
|
996
|
|
|
‡2
NTA|36417417X
|
|
996
|
|
|
‡2
NTA|325852987
|
|
996
|
|
|
‡2
BIBSYS|14068112
|
|
996
|
|
|
‡2
NII|DA04465232
|
|
996
|
|
|
‡2
DNB|1037564480
|
|
996
|
|
|
‡2
NDL|00476664
|
|
996
|
|
|
‡2
BNF|16441051
|
|
996
|
|
|
‡2
NUKAT|n 2018040843
|
|
996
|
|
|
‡2
RERO|A018205197
|
|
996
|
|
|
‡2
NTA|09055843X
|
|
996
|
|
|
‡2
LC|no2010174557
|
|
996
|
|
|
‡2
BAV|495_39337
|
|
996
|
|
|
‡2
ISNI|0000000388600221
|
|
996
|
|
|
‡2
ISNI|0000000394329693
|
|
996
|
|
|
‡2
ISNI|0000000390346402
|
|
996
|
|
|
‡2
NKC|kup20030000107894
|
|
996
|
|
|
‡2
BAV|495_171951
|
|
996
|
|
|
‡2
NTA|244649529
|
|
996
|
|
|
‡2
BIBSYS|90631180
|
|
996
|
|
|
‡2
NTA|327598131
|
|
996
|
|
|
‡2
BIBSYS|90284865
|
|
996
|
|
|
‡2
DNB|127207155
|
|
996
|
|
|
‡2
NTA|175599777
|
|
996
|
|
|
‡2
SUDOC|24479989X
|
|
996
|
|
|
‡2
ISNI|0000000393351901
|
|
996
|
|
|
‡2
DNB|1050781171
|
|
996
|
|
|
‡2
LC|nb 99008610
|
|
996
|
|
|
‡2
DE633|pe30036133
|
|
996
|
|
|
‡2
NUKAT|n 2017175220
|
|
996
|
|
|
‡2
NII|DA02024768
|
|
996
|
|
|
‡2
DE633|pe30031135
|
|
996
|
|
|
‡2
ISNI|0000000392169614
|
|
996
|
|
|
‡2
NTA|07087185X
|
|
996
|
|
|
‡2
PLWABN|9810593598605606
|
|
996
|
|
|
‡2
ISNI|0000000389355336
|
|
996
|
|
|
‡2
NKC|mub20201078663
|
|
996
|
|
|
‡2
RERO|A003947203
|
|
996
|
|
|
‡2
NTA|089731131
|
|
996
|
|
|
‡2
NTA|072734531
|
|
996
|
|
|
‡2
LC|no2005076714
|
|
996
|
|
|
‡2
NTA|073615080
|
|
996
|
|
|
‡2
ISNI|0000000012748201
|
|
996
|
|
|
‡2
ISNI|0000000116916994
|
|
996
|
|
|
‡2
NTA|133056740
|
|
996
|
|
|
‡2
DNB|12341105X
|
|
996
|
|
|
‡2
NTA|39775339X
|
|
996
|
|
|
‡2
DE633|pe51011996
|
|
996
|
|
|
‡2
ISNI|0000000395744434
|
|
996
|
|
|
‡2
BNF|12420674
|
|
996
|
|
|
‡2
DNB|1035462036
|
|
996
|
|
|
‡2
SUDOC|067070191
|
|
996
|
|
|
‡2
NUKAT|n 2003066336
|
|
996
|
|
|
‡2
ISNI|0000000044880215
|
|
996
|
|
|
‡2
NTA|131107763
|
|
996
|
|
|
‡2
N6I|vtls000039045
|
|
996
|
|
|
‡2
PTBNP|280302
|
|
996
|
|
|
‡2
DNB|12300215X
|
|
996
|
|
|
‡2
ISNI|0000000387312615
|
|
996
|
|
|
‡2
NTA|071183329
|
|
996
|
|
|
‡2
J9U|987007371413705171
|
|
996
|
|
|
‡2
NTA|067811795
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
|
998
|
|
|
‡a
Vogel, Jens-Uwe
‡2
DNB|118155571
‡3
exact title: (1.00, 'multimutatedherpessimplexvirusg207isapotentinhibitorofangiogenesis', 'multimutatedherpessimplexvirusg207isapotentinhibitorofangiogenesis')
|
